News: Akorn Inc (AKRX.O)

AKRX.O on Nasdaq

44.55USD
31 Oct 2014
Price Change (% chg)

$0.91 (+2.09%)
Prev Close
$43.64
Open
$44.45
Day's High
$44.73
Day's Low
$44.10
Volume
1,281,284
Avg. Vol
1,335,343
52-wk High
$45.25
52-wk Low
$20.08

Search Stocks
Select another date:

Thu, Sep 11 2014

Deals of the day- Mergers and acquisitions

(Updates EMC; Adds Akorn, Comcast, Grupos Salinas, Lucchini, Dentsu Aegis, Slovenske Elektrarne, Enel, BauMax, Verizon, Wind, BSkyB, Allergan, Hapag-Lloyd, Douglas, Eastman Chemical and Vodafone)

Exclusive: Akorn eyes $2 billion UCB unit in potential tax inversion - sources

NEW YORK - U.S. specialty drugmaker Akorn Inc is exploring a bid for Belgian drugmaker UCB SA's U.S. subsidiary, a deal that would allow the company to move its tax domicile overseas in a practice known as inversion, according to people familiar with the matter.

Akorn wins U.S. approval to buy VersaPharm

WASHINGTON - Pharmaceutical company Akorn Inc has won U.S. antitrust approval to buy specialty prescription drug company VersaPharm Inc on condition it sell its rights to a generic tuberculosis drug, the Federal Trade Commission said on Monday.

Akorn wins U.S. approval to buy VersaPharm

WASHINGTON, Aug 4 - Pharmaceutical company Akorn Inc has won U.S. antitrust approval to buy specialty prescription drug company VersaPharm Inc on condition it sell its rights to a generic tuberculosis drug, the Federal Trade Commission said on Monday.

Select another date:
Search Stocks